Search
Search
Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD
Show Description +
Marguerite B. McDonald, MD, FACS, moderates a panel discussion with Preeya K. Gupta, MD, and Douglas K. Devries, OD, to discuss how the Systane® iLux2® Thermal Pulsation System (Alcon) is using technology to bring symptomatic relief, as well as improve meibomian gland function in their patients. Dr. Gupta stresses the importance of the partnership between patient and clinician when managing this chronic disease.
Posted: 1/28/2022
Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD
Marguerite B. McDonald, MD, FACS, moderates a panel discussion with Preeya K. Gupta, MD, and Douglas K. Devries, OD, to discuss how the Systane® iLux2® Thermal Pulsation System (Alcon) is using technology to bring symptomatic relief, as well as improve meibomian gland function in their patients. Dr. Gupta stresses the importance of the partnership between patient and clinician when managing this chronic disease.
Posted: 1/28/2022
Perspectives On Prevalence, Gaps, and Management of MGD
About Alcon
Visit us online: ilux.myalcon.com
© 2022 Alcon Inc. 9/22 US-IL2-2200052
Indication: The Systane® iLux2® is indicated for the application of localized heat and pressure therapy in adult patients with meibomian gland dysfunction (MGD), which is associated with evaporative dry eye, and to capture/store digital images and video of the meibomian glands.
Contraindications:
Do NOT use the Systane® iLux2® in patients with the following conditions: Patients whose pupils have been pharmaceutically dilated; patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months); patients with active ocular herpes zoster or simplex of eye or eyelid or a history of these within prior 3 months; patients with cicatricial lid margin disease; patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months; patients with an ocular surface abnormality that may compromise corneal integrity; patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia; or patients with permanent makeup or tattoos on their eyelids.
Warnings/Precautions:
Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.
The Disposable may not fit all eyes, such as eyes with small palpebral fornices. Use of the Systane® iLux2® is NOT recommended in patients with the following conditions: moderate to severe allergic, vernal or giant papillary conjunctivitis; severe eyelid inflammation; systemic disease conditions that cause dry eye; in patients who are taking medications known to cause dryness; patients with punctal plugs, or patients who have undergone ocular surgery within prior 3 months.
Potential Adverse Reactions:
Potential adverse effects may occur because of the procedure. These effects include but are not limited to, the onset or increase in: eyelid/eye pain requiring discontinuation of the treatment procedure, eyelid irritation or inflammation, temporary reddening of the skin, ocular surface irritation or inflammation (e.g., corneal abrasion, conjunctival edema or conjunctival injection (hyperemia)), and ocular symptoms (e.g., burning, stinging, tearing, itching, discharge, redness, foreign body sensation, visual disturbance, sensitivity to light).
Attention: Please refer to the User Manual for a complete list of contraindications, instructions for use, warnings and precautions for the Systane® iLux2®.
